Is Perrigo (PRGO) Fully Valued After Its Recent Rebound?
Perrigo (PRGO) has moved sharply in recent sessions, which puts fresh attention on a business that sells over the counter health and wellness products across the US and Europe.
Perrigo’s recent surge has come after a string of strong short term share price returns, including a 21.53% 1 month move and a 53.73% 3 month gain. However, the 1 year total shareholder return is still down 16.24%, pointing to improving momentum rather than a completed turnaround.
Scan how Perrigo’s rebound compares with other potential turnaround candidates by reviewing the hand picked 20 high quality undiscovered gems that share solid fundamentals yet remain off most investors’ radar.
The recent jump has only brought Perrigo back toward analysts’ price target, not far beyond it. Is most of the upside already captured in this move, or does the current valuation still leave meaningful headroom?
Most Popular Narrative: 10% Undervalued
Perrigo is trading at $16.48 against a widely followed fair value estimate of $16.50, which puts the recent share price spike almost exactly in line with that narrative while still framing the stock as modestly undervalued on a discounted cash flow view.
Recent new business wins in US store-brand OTC have outpaced distribution losses for the first time since the 2024 reset. Net new contract gains are expected to add $75M+ to sales in the second half, directly supporting a step-change in revenue growth and operating income.
See why 13 investors see Perrigo as 0% undervalued.
Result: Fair Value of $16.50 (UNDERVALUED)
Still, the Perrigo narrative can be knocked off course if soft category demand persists, or if infant formula and OTC competition continue to pressure pricing and shelf space.
Find out about the key risks to this Perrigo narrative.
Next Steps
Momentum cuts both ways, and Perrigo’s mix of concerns and potential upside is sparking very different reactions among investors right now. Get closer to the raw numbers and sentiment by reviewing the 3 key rewards and 1 important warning sign.
Looking for more Perrigo sized investment ideas?
If Perrigo has your attention, do not stop here. Broaden your watchlist with ideas built from the same disciplined, data heavy process investors rely on.
- Target potential bargains by scanning for mispriced quality in the 33 high quality undervalued stocks that combine strong fundamentals with room for sentiment to catch up.
- Prioritise resilience first and filter for companies with sturdier finances using the list of solid balance sheet and fundamentals (25 results) before momentum headlines draw in the crowd.
- Protect your downside by focusing on stability and consistency across the 32 resilient stocks with low risk scores rather than chasing whatever just rallied the hardest.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com